ClearPoint Neuro (CLPT) Total Debt (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16% |
| Dec 31, 2025 | 68.05% |
| Sep 30, 2025 | 1.24% |
| Dec 31, 2023 | 0.14% |
| Sep 30, 2023 | 0.14% |
| Jun 30, 2023 | 0.14% |
| Mar 31, 2023 | 0.14% |
| Dec 31, 2022 | 0.14% |
| Sep 30, 2022 | 0.14% |
| Jun 30, 2022 | 0.14% |
| Mar 31, 2022 | 0.13% |
| Dec 31, 2021 | -44.14% |
| Sep 30, 2021 | 0.62% |
| Jun 30, 2021 | -28.60% |
| Mar 31, 2021 | -1.94% |
| Dec 31, 2020 | 2,690.18% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | -94.88% |
| Mar 31, 2020 | 744.19% |
| Dec 31, 2019 | 11.02% |
| Sep 30, 2019 | -0.10% |
| Jun 30, 2019 | -3.90% |
| Mar 31, 2019 | 0.26% |
| Dec 31, 2018 | 0.26% |
| Sep 30, 2018 | 49.00% |
| Jun 30, 2018 | 9.14% |
| Mar 31, 2018 | -39.62% |
| Dec 31, 2016 | -12.98% |
| Sep 30, 2016 | -20.63% |
| Jun 30, 2016 | -35.55% |
| Mar 31, 2016 | 326.30% |
| Dec 31, 2015 | -31.30% |
| Sep 30, 2015 | -63.69% |
| Jun 30, 2015 | -36.10% |
| Mar 31, 2015 | 13.33% |
| Dec 31, 2014 | -12.99% |
| Sep 30, 2014 | 13.04% |
| Jun 30, 2014 | -11.64% |
| Mar 31, 2014 | -5.89% |
| Dec 31, 2013 | 75.77% |
| Sep 30, 2013 | -34.88% |
| Jun 30, 2013 | -12.19% |
| Mar 31, 2013 | 83.16% |
| Dec 31, 2012 | 7.43% |
| Sep 30, 2012 | 1,657.45% |
| Jun 30, 2012 | 13.17% |
| Mar 31, 2012 | -0.56% |